Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment

OncoImmunology

Volumn 4, Issue 12, 2015, Pages

  Parodi, Monica ^a   Pedrazzi, Marco ^a   Cantoni, Claudia ^a,b   Averna, Monica ^a   Patrone, Mauro ^c   Cavaletto, Maria ^c   Spertino, Stefano ^c   Pende, Daniela ^d   Balsamo, Mirna ^a   Pietra, Gabriella ^a,d   Sivori, Simona ^a   Carlomagno, Simona ^a   Mingari, Maria Cristina ^a,d   Moretta, Lorenzo ^b   Sparatore, Bianca ^a   Vitale, Massimo ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

chemotaxis; HMGB1; melanoma cells; NK cells; tumor microenvironment

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIBODY; GAMMA INTERFERON; GRANZYME B; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 2; INTERLEUKIN 8; MEMBRANE PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEOME; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL INTERACTION; CELL KILLING; CELL MOTILITY; CELL STIMULATION; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOMODULATION; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TUMOR IMMUNITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 84944531740     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1052353     Document Type: Article

References (67)

1. M.Terme, E.Ullrich, N.F.Delahaye, N.Chaput, L.Zitvogel. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 2008; 9:486-94; PMID:18425105; http://dx.doi.org/10.1038/ni1580
2. M.A.Caligiuri. Human natural killer cells. Blood 2008; 112:461-69; PMID:18650461; http://dx.doi.org/10.1182/blood-2007-09-077438
3. E.Vivier, D.H.Raulet, A.Moretta, M.A.Caligiuri, L.Zitvogel, L.L.Lanier, W.M.Yokoyama, S.Ugolini. Innate or adaptive Immunity? The example of Natural Killer Cells. Science 2011; 331:44-9; PMID:21212348; http://dx.doi.org/10.1126/science.1198687
4. D.Pende, S.Marcenaro, M.Falco, S.Martini, M.E.Bernardo, D.Montagna, E.Romeo, C.Cognet, M.Martinetti, R.Maccario, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009; 113(13): 3119-29; PMID:18945967; http://dx.doi.org/10.1182/blood-2008-06-164103
5. C.Baier, A.Fino, C.Sanchez, L.Farnault, P.Rihet, B.Kahn-Perlès, R.T.Costello. Natural killer cells modulation in hematological malignancies. Front Immunol 2013; 4:459; PMID:24391641; http://dx.doi.org/10.3389/fimmu.2013.00459
6. M.Vitale, C.Cantoni, G.Pietra, M.C.Mingari, L.Moretta. Effect of tumor cells and tumor microenvironment on NK-cell function. Eur J Immunol 2014; 44(6): 1582-92; PMID:24777896; http://dx.doi.org/10.1002/eji.201344272
7. A.Stojanovic, A.Cerwenka. Natural killer cells and solid tumors. J Innate Immun 2011; 3(4): 355-64; PMID:21502747; http://dx.doi.org/10.1159/000325465
8. M.Balsamo, W.Vermi, M.Parodi, G.Pietra, C.Manzini, P.Queirolo, S.Lonardi, R.Augugliaro, A.Moretta, F.Facchetti, et al. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol 2012; 42:1833-42; PMID:22585684; http://dx.doi.org/10.1002/eji.201142179
9. E.Mamessier, A.Sylvain, M.L.Thibult, G.Houvenaeghel, J.Jacquemier, R.Castellano, A.Gonçalves, P.André, F.Romagné, G.Thibault, et al. Human breast cancer cells enhance self-tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
10. S.Platonova, J.Cherfils-Vicini, D.Damotte, L.Crozet, V.Vieillard, P.Validire, P.André, M.C.Dieu-Nosjean, M.Alifano, J.F.Régnard, et al. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 2011; 71:5412-22; PMID:21708957; http://dx.doi.org/10.1158/0008-5472.CAN-10-4179
11. N.Halama, M.Braun, C.Kahlert, A.Spille, C.Quack, N.Rahbari, M.Koch, J.Weitz, M.Kloor, I.Zoernig, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res 2011; 17:678-89; PMID:21325295; http://dx.doi.org/10.1158/1078-0432.CCR-10-2173
12. F.Ghiringhelli, C.Ménard, F.Martin, L.Zitvogel. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol Rev 2006; 214:229-38; PMID:17100888; http://dx.doi.org/10.1111/j.1600-065X.2006.00445.x
13. M.Balsamo, F.Scordamaglia, G.Pietra, C.Manzini, C.Cantoni, M.Boitano, P.Queirolo, W.Vermi, F.Facchetti, A.Moretta, et al. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci USA 2009; 106:20847-52; PMID:19934056; http://dx.doi.org/10.1073/pnas.0906481106
14. G.Pietra, C.Manzini, S.Rivara, M.Vitale, C.Cantoni, A.Petretto, M.Balsamo, R.Conte, R.Benelli, S.Minghelli, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544
15. A.El-Gazzar, V.Groh, T.Spies. Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer. J Immunol 2013; 191:1509-15; PMID:23913973; http://dx.doi.org/10.4049/jimmunol.1301071
16. M.Balsamo, C.Manzini, G.Pietra, F.Raggi, F.Blengio, M.C.Mingari, L.Varesio, L.Moretta, M.C.Bosco, M.Vitale. Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC. Eur J Immunol 2013; 43:2756-64; PMID:23913266; http://dx.doi.org/10.1002/eji.201343448
17. M.Wendel, I.E.Galani, E.Suri-Payer, A.Cerwenka. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 2008; 68(20): 8437-45; PMID:18922917; http://dx.doi.org/10.1158/0008-5472.CAN-08-1440
18. R.Castriconi, A.Dondero, F.Bellora, L.Moretta, A.Castellano, F.Locatelli, M.V.Corrias, A.Moretta, C.Bottino. Neuroblastoma-derived TGF-b1 modulates the chemokine receptor repertoire of human resting NK cells. J Immunol 2013; 190:5321-8; PMID:23576682; http://dx.doi.org/10.4049/jimmunol.1202693
19. D.Tang, R.Kang, H.J.Zeh3rd, M.T.Lotze. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799(1-2): 131-40; PMID:20123075; http://dx.doi.org/10.1016/j.bbagrm.2009.11.014
20. G.P.Sims, D.C.Rowe, S.T.Rietdijk, R.Herbst, A.J.Coyle. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28:367-88; PMID:20192808; http://dx.doi.org/10.1146/annurev.immunol.021908.132603
21. G.Li, X.Liang, M.T.Lotze. HMGB1: The Central Cytokine for All Lymphoid Cells. Front Immunol 2013; 4:68; PMID:23519706
22. E.Venereau, M.Casalgrandi, M.Schiraldi, D.J.Antoine, A.Cattaneo, F.De Marchis, J.Liu, A.Antonelli, A.Preti, L.Raeli, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012; 209(9): 1519-28; PMID:22869893; http://dx.doi.org/10.1084/jem.20120189
23. H.Yang, P.Lundbäck, L.Ottosson, H.Erlandsson-Harris, E.Venereau, M.E.Bianchi, Y.Al-Abed, U.Andersson, K.J.Tracey, D.J.Antoine. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 2012; 18:250-9; PMID:22105604; http://dx.doi.org/10.2119/molmed.2011.00389
24. C.Janko, M.Filipović, L.E.Munoz, C.Schorn, G.Schett, I.Ivanović-Burmazović, M.Herrmann. Redox Modulation of HMGB1-Related Signaling. Antioxid Redox Signal 2014; 20(7): 1075-85; PMID:23373897; http://dx.doi.org/10.1089/ars.2013.5179
25. D.Tang, R.Kang, C.W.Cheh, K.M.Livesey, X.Liang, N.E.Schapiro, R.Benschop, L.J.Sparvero, A.A.Amoscato, K.J.Tracey, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29(38): 5299-310; PMID:20622903; http://dx.doi.org/10.1038/onc.2010.261
26. H.Yang, D.J.Antoine, U.Andersson, K.J.Tracey. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013; 93(6): 865-73; PMID:23446148; http://dx.doi.org/10.1189/jlb.1212662
27. S.Nyström, D.J.Antoine, P.Lundbäck, J.G.Lock, A.F.Nita, K.Högstrand, A.Grandien, H.Erlandsson-Harris, U.Andersson, S.E.Applequist. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J 2013; 32(1): 86-99; PMID:23222484; http://dx.doi.org/10.1038/emboj.2012.328
28. C.Semino, G.Angelini, A.Poggi, A.Rubartelli. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005; 106:609-16; PMID:15802534; http://dx.doi.org/10.1182/blood-2004-10-3906
29. C.Semino, J.Ceccarelli, L.V.Lotti, M.R.Torrisi, G.Angelini, A.Rubartelli. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol 2007; 81:92-9; PMID:16997859; http://dx.doi.org/10.1189/jlb.0306172
30. M.A.Ivarsson, J.Michaëlsson, C.Fauriat. Activating killer cell Ig-like receptors in health and disease. Front Immunol 2014; 5:184; PMID:24795726; http://dx.doi.org/10.3389/fimmu.2014.00184
31. J.H.Russell, T.J.Ley. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20:323-70; PMID:11861606; http://dx.doi.org/10.1146/annurev.immunol.20.100201.131730
32. S.Marcenaro, F.Gallo, S.Martini, A.Santoro, G.M.Griffiths, M.Aricó, L.Moretta, D.Pende. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006; 108(7): 2316-23; PMID:16778144; http://dx.doi.org/10.1182/blood-2006-04-015693
33. D.Yang, Q.Chen, H.Yang, K.J.Tracey, M.Bustin, J.J.Oppenheim. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007; 81(1): 59-66; PMID:16966386; http://dx.doi.org/10.1189/jlb.0306180
34. J.Deguine, B.Breart, F.Lemaître, J.P.Di Santo, P.Bousso. Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression. Immunity 2010; 33(4): 632-44; PMID:20951068; http://dx.doi.org/10.1016/j.immuni.2010.09.016
35. L.Apetoh, F.Ghiringhelli, A.Tesniere, M.Obeid, C.Ortiz, A.Criollo, G.Mignot, M.C.Maiuri, E.Ullrich, P.Saulnier, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622
36. C.A.Wild, C.Bergmann, G.Fritz, P.Schuler, T.K.Hoffmann, R.Lotfi, A.Westendorf, S.Brandau, S.Lang. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int Immunol 2012; 24(8): 485-94; PMID:22473704; http://dx.doi.org/10.1093/intimm/dxs051
37. S.Jube, Z.S.Rivera, M.E.Bianchi, A.Powers, E.Wang, I.Pagano, H.I.Pass, G.Gaudino, M.Carbone, H.Yang. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 2012; 72(13): 3290-301; PMID:22552293; http://dx.doi.org/10.1158/0008-5472.CAN-11-3481
38. C.W.Bell, W.Jiang, C.F.Reich3rd, D.S.Pisetsky. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291(6): C1318-25; PMID:16855214; http://dx.doi.org/10.1152/ajpcell.00616.2005
39. H.Kazama, J.E.Ricci, J.M.Herndon, G.Hoppe, D.R.Green, T.A.Ferguson. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29(1): 21-32; PMID:18631454; http://dx.doi.org/10.1016/j.immuni.2008.05.013
40. S.Chiba, M.Baghdadi, H.Akiba, H.Yoshiyama, I.Kinoshita, H.Dosaka-Akita, Y.Fujioka, Y.Ohba, J.V.Gorman, J.D.Colgan, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012; 13:832-42; PMID:22842346; http://dx.doi.org/10.1038/ni.2376
41. M.Schiraldi, A.Raucci, L.M.Muñoz, E.Livoti, B.Celona, E.Venereau, T.Apuzzo, F.De Marchis, M.Pedotti, A.Bachi, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012; 209(3): 551-63; PMID:22370717; http://dx.doi.org/10.1084/jem.20111739
42. M.Pedrazzi, M.Averna, B.Sparatore, M.Patrone, F.Salamino, M.Marcoli, G.Maura, C.Cervetto, D.Frattaroli, S.Pontremoli, E.Melloni. Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS One 2012; 7(8): e44518; PMID:22952988; http://dx.doi.org/10.1371/journal.pone.0044518
43. A.P.Mashkina, O.V.Tyulina, T.I.Solovyova, E.I.Kovalenko, L.M.Kanevski, P.Johnson, A.A.Boldyrev. The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem Int 2007; 51:356-60; PMID:17543418; http://dx.doi.org/10.1016/j.neuint.2007.04.009
44. L.C.Ndhlovu, S.Lopez-Vergès, J.D.Barbour, R.B.Jones, A.R.Jha, B.R.Long, E.C.Schoeffler, T.Fujita, D.F.Nixon, L.L.Lanier. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012; 119(16): 3734-43; PMID:22383801; http://dx.doi.org/10.1182/blood-2011-11-392951
45. R.Adachi, K.Takeuchi, K.Suzuki. Antisense oligonucleotide to cofilin enhances respiratory burst and phagocytosis in opsonized zymosan-stimulated mouse macrophage J774.1 cells. J Biol Chem 2002; 277:45566-71; PMID:12297504; http://dx.doi.org/10.1074/jbc.M207419200
46. S.Sivori, D.Olive, M.Lopez-Botet, M.Vitale. NK receptors: tools for a polyvalent cell family. Front Immunol 2014; 5:617; PMID:25520722
47. G.Pietra, C.Manzini, M.Vitale, M.Balsamo, E.Ognio, M.Boitano, P.Queirolo, L.Moretta, M.C.Mingari. Natural Killer cells kill human melanoma cells with phenotypic characteristics of cancer stem cells. Int. Immunol 2009; 21:793-801
48. M.Pedrazzi, M.Patrone, M.Passalacqua, E.Ranzato, D.Colamassaro, B.Sparatore, S.Pontremoli, E.Melloni. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol 2007; 179:8525-32; PMID:18056400; http://dx.doi.org/10.4049/jimmunol.179.12.8525
49. J.L.Harris, E.P.Peterson, D.Hudig, N.A.Thornberry, C.S.Craik. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem 1998; 273(42): 27364-73; PMID:9765264; http://dx.doi.org/10.1074/jbc.273.42.27364
50. S.Spertino, V.Cipriani, C.De Angelis, M.G.Giuffrida, F.Marsano, M.Cavaletto. Proteome profile and biological activity of caprine, bovine and human milk fat globules. Mol Biosyst 2012; 8:967-74; PMID:22193558; http://dx.doi.org/10.1039/C2MB05400K
51. T.Hirata, A.Nomachi, K.Tohya, M.Miyasaka, S.Tsukita, T.Watanabe, S.Narumiya. Moesin-deficient mice reveal a non-redundant role for moesin in lymphocyte homeostasis. Int Immunol 2012; 24:705-17; PMID:22875842; http://dx.doi.org/10.1093/intimm/dxs077
52. M.Bîcu, M.Moţa, N.M.Panduru, C.Grăunţeanu, E.Moţa. Oxidative stress in diabetic kidney disease. Rom J Intern Med 2010; 48:307-12
53. L.A.Pescatore, D.Bonatto, F.L.Forti, A.Sadok, H.Kovacic, F.R.Laurindo. Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation. J Biol Chem 2012; 287:29290-300; PMID:22773830; http://dx.doi.org/10.1074/jbc.M112.394551
54. F.You, H.Sun, X.Zhou, W.Sun, S.Liang, Z.Zhai, Z.Jiang. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 2009; 10:1300-8; PMID:19881509; http://dx.doi.org/10.1038/ni.1815
55. A.Bouter, C.Gounou, R.Bérat, S.Tan, B.Gallois, T.Granier, B.L.d'Estaintot, E.Pöschl, B.Brachvogel, A.R.Brisson. Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair. Nat Commun 2011; 2:270; PMID:21468022; http://dx.doi.org/10.1038/ncomms1270
56. U.Zimmermann, S.Balabanov, J.Giebel, S.Teller, H.Junker, D.Schmoll, C.Protzel, C.Scharf, B.Kleist, R.Walther. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 2004; 209:111-8; PMID:15145526; http://dx.doi.org/10.1016/j.canlet.2003.12.002
57. S.Fukuda, D.W.Wu, K.Stark, L.M.Pelus. Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochem Biophys Res Commun 2002; 292:593-600; PMID:11922608; http://dx.doi.org/10.1006/bbrc.2002.6680
58. L.Jiang, J.M.Phang, J.Yu, S.J.Harrop, A.V.Sokolova, A.P.Duff, K.E.Wilk, H.Alkhamici, S.N.Breit, S.M.Valenzuela, et al. CLIC proteins, ezrin, radixin, moesin and the coupling of membranes to the actin cytoskeleton: A smoking gun? Biochim Biophys Acta 2013; 1838(2):643-57; PMID:23732235; http://dx.doi.org/10.1016/j.bbamem.2013.05.025
59. J.W.Wang, S.Y.Peng, J.T.Li, Y.Wang, Z.P.Zhang, Y.Cheng, D.Q.Cheng, W.H.Weng, X.S.Wu, X.Z.Fei, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009; 281:71-81; PMID:19299076; http://dx.doi.org/10.1016/j.canlet.2009.02.020
60. S.Dütting, S.Brachs, D.Mielenz. Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun Signal 2011; 9:2; PMID:21244694; http://dx.doi.org/10.1186/1478-811X-9-2
61. T.B.Zhou, Y.H.Qin. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res 2013; 33:28-36; PMID:23327602; http://dx.doi.org/10.3109/10799893.2012.752006
62. X.Li, A.Y.Lee. Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase. J Biol Chem 2010; 285:32436-45; PMID:20696765; http://dx.doi.org/10.1074/jbc.M110.120451
63. P.G.Board, D.Menon. Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta 2013; 1830:3267-88; PMID:23201197; http://dx.doi.org/10.1016/j.bbagen.2012.11.019
64. M.J.Pérez, A.I.Cederbaum. Adenovirus-mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity. Hepatology 2003; 38:1146-58; http://dx.doi.org/10.1053/jhep.2003.50479
65. M.Caraglia, M.H.Park, E.C.Wolff, M.Marra, A.Abbruzzese. eIF5A isoforms and cancer: two brothers for two functions? Amino Acids 2013; 44:103-9; PMID:22139412; http://dx.doi.org/10.1007/s00726-011-1182-x
66. J.W.Zhao, Z.L.Gao, Q.Y.Ji, H.Wang, H.Y.Zhang, Y.D.Yang, F.J.Xing, L.J.Meng, Y.Wang. Regulation of cofilin activity by CaMKII and calcineurin. Am J Med Sci 2012; 344:462-72; PMID:22270398; http://dx.doi.org/10.1097/MAJ.0b013e318244745b
67. S.Bergink, F.A.Salomons, D.Hoogstraten, T.A.Groothuis, H.de Waard, J.Wu, L.Yuan, E.Citterio, A.B.Houtsmuller, J.Neefjes, et al. DNA damage triggers nucleotide excision repair dependent monoubiquitylation of histone H2A. Genes Dev 2006; 20:1343-52; PMID:16702407; http://dx.doi.org/10.1101/gad.373706